StockData
Cardinal Health Inc logo

Cardinal Health Inc

CAHNYSEWholesale-Drugs, Proprietaries & Druggists' SundriesFiscal year ends June 30
Financials through Q4 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 16/3040% above fair value
$272.34−5.98 (-2.15%)

Close on Nov 19, 2026Market cap $63.34BP/E 37.7Yield 0.75%

Cardinal Health Global Medical Products & Distribution Segment Profit by Quarter

Global Medical Products & Distribution (GMPD) Segment Profit Margin (%) (%)

Periods

Cardinal Health Global Medical Products & Distribution Segment Profit: 1.0% in Q1 FY27, down 0.4 pts from a year earlier.

Latest, Q1 FY27
1.0%
Period ended Sep 30, 2026 (CQ3 2026)
Change on a year earlier
-0.4 pts
1.4% in Q1 FY26
History
15 quarters
Since Q3 FY23
Sources
11
Documents cited below

Where the Q1 FY27 figure comes from

Source: CAH SEC Form 8-K (filed 2026-11-05) ↗

Segment profit margin tracking Cardinal Health's 5-Point GMPD Turnaround Plan execution across Cardinal Health Brand medical-surgical manufacturing and distribution.

quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedGlobal Medical Products & Distribution (GMPD) Segment Profit Margin (%) (%)Year on yearSource
Q1 FY27CQ3 2026Sep 30, 20261.0%-0.4 ptsCAH SEC Form 8-K (filed 2026-11-05) ↗
Q4 FY26CQ2 2026Jun 30, 20264.8%+2.6 ptsCAH SEC Form 8-K (filed 2026-08-11) ↗
Q3 FY26CQ1 2026Mar 31, 20260.8%-0.4 ptsCAH SEC Form 8-K (filed 2026-04-30) ↗
Q2 FY26CQ4 2025Dec 31, 20251.1%+0.6 ptsCAH SEC Form 8-K (filed 2026-02-05) ↗
Q1 FY26CQ3 2025Sep 30, 20251.4%+1.2 ptsCAH SEC Form 8-K (filed 2026-11-05) ↗
Q4 FY25CQ2 2025Jun 30, 20252.2%+0.7 ptsCAH SEC Form 8-K (filed 2026-08-11) ↗
Q3 FY25CQ1 2025Mar 31, 20251.2%+0.5 ptsCAH SEC Form 8-K (filed 2026-04-30) ↗
Q2 FY25CQ4 2024Dec 31, 20240.6%+0.2 ptsCAH SEC Form 8-K (filed 2026-02-05) ↗
Q1 FY25CQ3 2024Sep 30, 20240.3%-0.1 ptsCAH SEC Form 8-K (filed 2025-10-30) ↗
Q4 FY24CQ2 2024Jun 30, 20241.5%+1.3 ptsCAH SEC Form 8-K (filed 2025-08-12) ↗
Q3 FY24CQ1 2024Mar 31, 20240.7%+2.3 ptsCAH SEC Form 8-K (filed 2025-05-01) ↗
Q2 FY24CQ4 2023Dec 31, 20230.4%–CAH SEC Form 8-K (filed 2025-01-30) ↗
Q1 FY24CQ3 2023Sep 30, 20230.4%–CAH SEC Form 8-K (filed 2024-11-01) ↗
Q4 FY23CQ2 2023Jun 30, 20230.2%–CAH SEC Form 8-K (filed 2024-08-14) ↗
Q3 FY23CQ1 2023Mar 31, 2023-1.5%–CAH SEC Form 8-K (filed 2024-05-02) ↗

Breakdown

What makes up global Medical Products & Distribution Segment Profit

Cite this data

StockData. (2026). Cardinal Health Global Medical Products & Distribution Segment Profit (%), quarterly Q3 FY23–Q1 FY27 [Data set]. Compiled from Cardinal Health SEC filings and investor materials. https://stockdatahq.com/stocks/cah/kpis/core-gmpd-margin

See every metric in the Cardinal Health KPI table. Data updated Nov 7, 2026.

See a number that looks wrong?